Arteris’ (AIP) Buy Rating Reaffirmed at Rosenblatt Securities

Rosenblatt Securities reissued their buy rating on shares of Arteris (NASDAQ:AIP) in a research report released on Friday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the stock.

Separately, Wedbush reiterated an outperform rating and issued a $17.00 price target on shares of Arteris in a research note on Tuesday, February 20th.

Arteris Stock Up 38.4 %

AIP opened at $8.21 on Friday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.26 and a current ratio of 1.26. The stock has a fifty day moving average of $6.95 and a 200-day moving average of $6.19. Arteris has a fifty-two week low of $3.82 and a fifty-two week high of $8.24. The company has a market capitalization of $315.02 million, a P/E ratio of -7.97 and a beta of 1.04.

Arteris (NASDAQ:AIP) last issued its quarterly earnings data on Tuesday, February 20th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The business had revenue of $12.50 million during the quarter, compared to analyst estimates of $11.90 million. Arteris had a negative return on equity of 170.93% and a negative net margin of 69.70%. On average, equities analysts expect that Arteris will post -0.9 EPS for the current year.

Insiders Place Their Bets

In other Arteris news, COO Laurent R. Moll sold 4,191 shares of the firm’s stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $7.03, for a total value of $29,462.73. Following the transaction, the chief operating officer now directly owns 588,887 shares of the company’s stock, valued at approximately $4,139,875.61. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Arteris news, VP Paul L. Alpern sold 11,250 shares of the firm’s stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $6.39, for a total value of $71,887.50. Following the sale, the vice president now owns 81,042 shares in the company, valued at $517,858.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Laurent R. Moll sold 4,191 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $7.03, for a total value of $29,462.73. Following the sale, the chief operating officer now owns 588,887 shares in the company, valued at approximately $4,139,875.61. The disclosure for this sale can be found here. Insiders have sold 80,264 shares of company stock worth $561,883 over the last ninety days. Corporate insiders own 36.10% of the company’s stock.

Hedge Funds Weigh In On Arteris

Large investors have recently bought and sold shares of the company. GSA Capital Partners LLP increased its stake in shares of Arteris by 26.9% in the first quarter. GSA Capital Partners LLP now owns 132,952 shares of the company’s stock valued at $973,000 after buying an additional 28,165 shares during the period. Worth Venture Partners LLC boosted its position in Arteris by 114.3% during the 4th quarter. Worth Venture Partners LLC now owns 109,921 shares of the company’s stock worth $647,000 after buying an additional 58,620 shares during the period. Roubaix Capital LLC grew its holdings in Arteris by 34.5% during the 4th quarter. Roubaix Capital LLC now owns 342,664 shares of the company’s stock worth $2,018,000 after acquiring an additional 87,920 shares during the last quarter. Victory Capital Management Inc. acquired a new position in Arteris in the 4th quarter valued at approximately $60,000. Finally, Acuitas Investments LLC raised its stake in shares of Arteris by 150.3% during the fourth quarter. Acuitas Investments LLC now owns 215,991 shares of the company’s stock valued at $1,272,000 after acquiring an additional 129,692 shares during the last quarter. 64.36% of the stock is currently owned by institutional investors.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.